CRP and Alzheimer disease: Elevated plasma levels of C-reactive protein (CRP) shortened the latency for the onset of clinical AD symptoms, and the authors concluded that treating chronic systemic inflammation based on genetic risk might be considered an effective prevention method for premature development of AD symptoms.